Introduction The introduction of tyrosine kinase inhibitors (TKIs) has revolutionized the
therapy of chronic myeloid leukemia (CML). Although the efficacy of TKIs is beyond dispute …

With survival expectation that of age-matched controls and given excellent response and
worldwide access to tyrosine kinase inhibitors (TKI), family planning is increasingly …

The success of tyrosine kinase inhibitors (TKIs) in the treatment of chronic myeloid
leukaemia (CML) has resulted in a return to a normal life expectancy for the majority of …

Purpose Despite the general recommendation to avoid Tyrosine Kinase Inhibitors (TKIs) for
Chronic Myeloid Leukemia (CML) during pregnancy, unplanned pregnancies still occur …

The management of patients with chronic myeloid leukemia (CML) during pregnancy is a
matter of continuous debate. The introduction of the tyrosin kinase inhibitors (TKIs) in clinical …

Background The aim of this study was to explore outcomes of planned pregnancy in female
patients with chronic myeloid leukemia (CML) on tyrosine kinase inhibitors (TKIs). Materials …

The management of patients with chronic myeloid leukemia (CML) during pregnancy
remains a matter of continuous debate. Tyrosine kinase inhibitors (TKIs) have become the …

Introduction: Since the introduction of tyrosine kinase inhibitors (TKIs) therapy, chronic
myeloid leukemia (CML), has moved from a fatal illness to a manageable disease with a …

Background The aim of this work was to report on the outcome of pregnancy in patients with
chronic myeloid leukaemia who were on tyrosine kinase inhibitor treatment. Patients and …

Background: Exposure to TKI has teratogenic effects in animal studies and humans. CML is
being identified in younger patients who need to continue treatment for long periods of time …